News Major shareholder announcement – BlackRock, Inc. Staff September 11, 2023 Iframe sync Post navigation Previous: Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 Next: Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston More Stories Healthcare News TempraMed Closes C$2.5 Million Fully Subscribed Private Placement Staff January 12, 2026 Mental Health News TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time Staff January 12, 2026 Healthcare News Pregnancy Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology Staff January 12, 2026
